Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00561678 · ClinicalTrials.gov registry record · Phase 4
Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve
A Phase 4 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 404
- Enrollment target
NCT00561678 is a Phase 4 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 404 participants.
The verdict
NCT00561678, a Phase 4 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 404 participants
- Enrollment target
Study Summary
Elderly patients who undergo anesthesia and non-cardiac surgery are subject to deterioration of brain function including the development of postoperative delirium (PD) and postoperative cognitive dysfunction (POCD). These disorders cause disability, distress for both patients and their families, are associated with other medical complications and account for significant additional health care costs. We currently use relatively primitive approaches to preventing and treating PD and POCD. Dexmedetomidine is a drug used for sedation in critically ill patients that provides some pain relief and controls the bodies response to stress. The sedation produced by dexmedetomidine appears more similar to natural sleep than any other drug used for anesthesia and postoperative sedation. Data suggesting that dexmedetomidine can prevent delirium following cardiac surgery and the developing understanding of the causes of PD and POCD suggest that dexmedetomidine will be particularly effective.
Interventions
- DRUG Placebo
- DRUG Precedex (Dexmedetomidine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00561678
The ClinicalTrials.gov registry entry for NCT00561678 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 404 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00561678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00561678 about?
NCT00561678 is a clinical study titled "Perioperative Cognitive Function - Dexmedetomidine and Cognitive Reserve". Elderly patients who undergo anesthesia and non-cardiac surgery are subject to deterioration of brain function including the development of postoperative delirium (PD) and postoperative cognitive dysfunction (POCD). These disorders cause disability, distress for both patients and their families, are...
What is the current status of trial NCT00561678?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 404 participants. The study started on 2008-02. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00561678?
The interventions under investigation include: Placebo (DRUG), Precedex (Dexmedetomidine) (DRUG).
Who is sponsoring clinical trial NCT00561678?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.